Trials / Completed
CompletedNCT01565577
Evaluation of Immune Response Against the Strain of Neisseria Meningitidis B: 14, P1-7, 16 Patients Vaccinated With MenBVac® (Extension MenbVac)
Phase 3, Vaccinal Activity Assessment of MenBVac Against Nesseiria Menigitidis B:14,P1.7,16 Strain in Child Vaccinated With MenBVac®
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 117 (actual)
- Sponsor
- University Hospital, Rouen · Academic / Other
- Sex
- All
- Age
- 7 Years – 12 Years
- Healthy volunteers
- Accepted
Summary
This study aims to estimate the vaccinal immunity four years after four doses of MenbVac in children aged 4-8 years.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | MenbVac | Blood test |
Timeline
- Start date
- 2012-04-01
- Primary completion
- 2012-06-01
- Completion
- 2012-09-01
- First posted
- 2012-03-28
- Last updated
- 2014-09-08
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01565577. Inclusion in this directory is not an endorsement.